The Plasma Therapy Market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028. The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, increasing awareness towards PRP therapies; the rising prevalence of musculoskeletal, sports, & orthopedic injuries; and the growing number of cosmetic procedures worldwide.
In addition, increasing PRP treatments and advancing healthcare in emerging economies are likely to offer significant growth opportunities for platelet rich plasma therapy providers.
However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Also, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.
Click here to: Get Free Sample Pages of this Report
Impact of COVID-19 Pandemic on the Plasma Therapy Market
The outbreak of the COVID-19 pandemic and the lockdowns implemented by governments to control the spread of the disease impacted various industries. The upsurge of COVID-19 infected patients affected the management of hospitals due to its limited resources and staff compared to the sudden growth in the number of infected patients, which led to a delay in some of the surgeries and medical procedures. The procedures that were not life-threatening were delayed, and medical procedures that would have severely impacted patients and even caused loss of life if not carried out were prioritized.
The platelet-rich plasma (PRP) is mainly used in cosmetics, dermatology, orthopedics, dental procedures & oral surgeries, and sports medicine. The disorders and treatments associated with these problems are usually non-life-threatening. Therefore, PRP treatments to patients with these medical requirements were not prioritized. For instance, according to the American Society of Plastic Surgeons (ASPS), the PRP procedures for cosmetics in the U.S. fell to 231,140 procedures in 2020, from 275,101 procedures in 2019, with a decline of 16%.
Manufacturers, business owners, and suppliers of PRP therapy products within Asian economies were impacted severely by the rapid growth in the number of patients. During the outbreak, low- and middle-income countries faced more challenges due to underdeveloped health infrastructures and restrictions imposed by the authorities on suppliers and industries. The pandemic led to a significant decrease in PRP demand in regenerative medicine and pain management such as, tennis elbow, arthritis, torn ligaments, and cosmetic & plastic surgeries.
Lockdowns were implemented worldwide to stop the transmission of the disease. The implementation of lockdown and other preventative measures impacted the supply chain and the availability of medical devices. It also affected the revenue of the companies and led to an increase in unemployment. For instance, according to a statement given by Tricell Bio, a manufacturer of PRP kits based in India, COVID-19 has impacted the business across all the industries and hopes to recover from the setback soon.
The COVID-19 outbreak severely impacted the countries in the Southeast Asian region as several countries from this region depend on export and tourism for revenue generation. Also, medical tourism suffered significant losses due to travel restrictions. For instance, according to the Malaysian Health Tourism Council (MHTC), medical tourism in the country reported a decline by 75% in revenues in 2020 ($120 million) compared to 2019. The negative impact on health tourism due to the pandemic resulted in the decrease in the adoption of PRP treatments, decreasing the usage of PRP products.
Key Findings in the Global Plasma Therapy Market Study
The Leukocyte-rich PRP Segment Expected to Grow at the Highest CAGR During Forecast Period
Based on type, the global platelet rich plasma market is segmented into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte and platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Little or no risks associated with pure PRP and its ability to accelerate the healing process of tissue, tendons, and bones are the factors driving the demand for pure PRP in the market. On the other hand, the increasing use of L-PRP in patients suffering from osteoarthritis of the knee and hips and positive effects of L-PRP in certain medical applications for therapeutic purposes are expected to account for the high growth of the leukocyte–rich PRP segment during the forecast period.
The Dermatology and Cosmetology Segment Expected to Grow at the Highest CAGR During Forecast Period
Based on application, the global platelet rich plasma market is segmented into orthopedics & traumatology, rheumatology, dermatology & cosmetology, ophthalmology, stomatology & odontology, and other applications. The dermatology & cosmetology segment is expected to grow at the highest CAGR during the forecast period. The rising number of patients with skin and hair-related conditions, growing beauty consciousness amongst the general population, and increasing adoption of microneedling for cosmetic purposes support the market growth of this segment.
The Hospitals & Clinics Segment Estimated to Account for the Largest Share of Global PRP Therapy Market in 2021
Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The large share of this segment is attributed to factors such as the increase in healthcare spending and growing awareness and prescriptions for PRP treatments and procedures to patients for various medical conditions.
North America Estimated to Account for Largest Share of Global PRP Therapy Market in 2021
Based on geography, the PRP therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global PRP therapy market. The region’s largest market share is primarily attributed to the presence of leading platelet rich plasma therapy product manufacturers, growing awareness toward advantages of platelet rich plasma therapies, active involvement of academic and research institutes to conduct advanced research and development, and support from government and regulatory authorities to promote the use of PRP for medical applications.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that market participants adopted over the past four years. The key players profiled in the global platelet-rich plasma therapy market report include Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).
Scope of the Report:
Platelet Rich Plasma Therapy Market, by Type
Platelet Rich Plasma Therapy Market, by Application
Platelet Rich Plasma Therapy Market, by End User
Platelet Rich Plasma Therapy Market, by Geography
Key questions answered in the report:
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Drivers
4.1.1. Advantages Offered by PRP Treatment
4.1.2. Increasing Awareness Toward PRP Therapies
4.1.3. Rising Prevalence of Musculoskeletal and Sports Injuries
4.1.4. Growing Number of Cosmetic Procedures Worldwide
4.2. Restraints
4.2.1. Availability of Alternatives for PRP Treatment
4.2.2. Side-Effects Associated with the Use of PRP
4.3. Opportunities
4.3.1. Increasing Applications of PRP Treatments
4.3.2. Advancing Healthcare in Emerging Economies
4.4. Challenge
4.4.1. Stringent Regulatory Framework for the Use of PRP
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Competitive Rivalry
5. Impact of COVID-19 on the Global Platelet Rich Plasma Market
6. PRP Qualification Criteria
7. PRP Therapy Market Trends
8. Platelet Rich Plasma Therapy Market, by Type
8.1. Introduction
8.2. Pure PRP
8.3. Leukocyte-Rich PRP
8.4. Pure Platelet Rich Fibrin
8.5. Leukocyte And Platelet Rich Fibrin (L-PRF)
9. Platelet Rich Plasma (PRP) Therapy Market, by Application
9.1. Introduction
9.2. Orthopedics & Traumatology
9.3. Rheumatology
9.4. Dermatology & Cosmetology
9.5. Opthalmology
9.6. Stomatology & Odontology
9.7. Other Applications
10. Platelet Rich Plasma Therapy Market, by End User
10.1. Introduction
10.2. Hospitals & Clinics
10.3. Research Institutes
11. Platet Rich Plasma Therapy Market, by Geography
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe (RoE)
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia-Pacific (RoAPAC)
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
12. Competitive Landscape
12.1. Introduction
12.2. Key Growth Strategies
12.3. Market Share Analysis (2020)
12.3.1. DePuy Synthes, Inc. (U.S.)
12.3.2. Stryker Corporation (U.S.)
12.3.3. Zimmer Biomet Holdings, Inc. (U.S.)
12.3.4. Terumo Corporation (Japan).
12.4. Key Players SWOT Analysis
12.4.1. Zimmer Biomet Holdings, Inc.
12.4.1.1. Strengths
12.4.1.2. Weaknesses
12.4.1.3. Opportunities
12.4.1.4. Threats
12.4.2. Terumo Corporation
12.4.2.1. Strengths
12.4.2.2. Weaknesses
12.4.2.3. Opportunities
12.4.2.4. Threats
12.4.3. Arthrex, Inc.
12.4.3.1. Strengths
12.4.3.2. Weaknesses
12.4.3.3. Opportunities
12.4.3.4. Threats
12.4.4. DePuy Synthes, Inc. (Johnson &Johnson)
12.4.4.1. Strengths
12.4.4.2. Weaknesses
12.4.4.3. Opportunities
12.4.4.4. Threats
12.4.5. Stryker Corporation
12.4.5.1. Strengths
12.4.5.2. Weaknesses
12.4.5.3. Opportunities
12.4.5.4. Threats
12.5. Funding and Grants Assessment
13. Company Profiles
13.1. Arthrex, Inc.
13.1.1. Business Overview
13.1.2. Product Portfolio
13.1.3. Strategic Developments
13.2. DePuy Synthes, Inc. (Johnson & Johnson)
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Product Portfolio
13.3. Dr PRP USA LLC
13.3.1. Business Overview
13.3.2. Product Portfolio
13.4. Emcyte Corporation
13.4.1. Business Overview
13.4.2. Product Portfolio
13.4.3. Strategic Developments
13.5. Exactech, Inc.
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Product Portfolio
13.6. Global Stem Cells Group, Inc.
13.6.1. Business Overview
13.6.2. Product Portfolio
13.6.3. Strategic Developments
13.7. Celling Biosciences, Inc
13.7.1. Business Overview
13.7.2. Product Portfolio
13.8. Terumo Corporation
13.8.1. Business Overview
13.8.2. Financial Overview
13.8.3. Product Portfolio
13.9. Regen Lab SA
13.9.1. Business Overview
13.9.2. Product Portfolio
13.10. Stryker Corporation
13.10.1. Business Overview
13.10.2. Financial Overview
13.10.3. Product Portfolio
13.10.4. Strategic Developments
13.11. Zimmer Biomet Holdings, Inc.
13.11.1. Business Overview
13.11.2. Financial Overview
13.11.3. Product Portfolio
13.12. Juventix Regenerative Medical, Llc
13.12.1. Business Overview
13.12.2. Product Portfolio
14. Appendix
14.1. Questionnaire
14.2. Available Customization
List of Tables
Table 1 Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021–2028)
Table 2 Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
Table 3 Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021–2028)
Table 4 Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
Table 5 Current Indications for Which PRP Therapy Is Used
Table 6 Ongoing Research in New Medical Fields Regarding PRP Therapy
Table 7 Global Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 8 Global Pure PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9 Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10 Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11 Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 13 List of Clinical Trials with PRP for Orthopedic Applications
Table 14 Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
Table 15 Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019–2028 (USD Million)
Table 16 Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
Table 17 Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019–2028 (USD Million)
Table 18 List of Research Trials for Dermatology & Cosmetology
Table 19 Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
Table 20 Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019–2028 (USD Million)
Table 21 Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
Table 22 Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019–2028 (USD Million)
Table 23 Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
Table 24 Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019–2028 (USD Million)
Table 25 Clinical Trials with PRP Therapy in Other Applications
Table 26 Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
Table 27 Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 28 Global Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 29 Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 30 Various Ongoing Researches for Platelet Rich Plasma
Table 31 Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 32 Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33 North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019–2028 (USD Million)
Table 34 North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 35 North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 36 North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 37 U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 38 U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 39 U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 40 Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 41 Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 42 Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 43 Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44 Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 45 Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 46 Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 47 Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 48 Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 49 Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 50 France: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 51 France: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 52 France: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 53 U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 54 U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 55 U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 56 Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 57 Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 58 Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 59 Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 60 Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 61 Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019–2028 (USD Million)
Table 62 Fertility Rate total (Birth Per Woman)
Table 63 RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 64 RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 65 RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 66 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 67 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 68 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 69 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 70 Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 71 Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 72 Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 73 China: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 74 China: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 75 China: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 76 India: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 77 India: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 78 India: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 79 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 80 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 81 RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 82 Health Expenditure Per Capita In Latin American Countries
Table 83 Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84 Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 85 Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 86 Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 87 Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 88 Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 89 Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 90 Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 91 Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 92 Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 93 Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 94 Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 95 Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 96 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 97 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 98 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 99 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 100 Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 101 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 102 Number of Developments by the Major Players During 2018–2021
Table 103 Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
Table 104 Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9 Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10 Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
Figure 11 Market Dynamics
Figure 12 Porter’s Five forces Analysis: Platelet Rich Plasma Therapy Market
Figure 13 Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
Figure 14 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 15 Global Platelet Rich Plasma Therapy Market Size, by End User, 2021–2028 (USD Million)
Figure 16 Number of Research Published over The Years for Platelet Rich Plasma Therapy
Figure 17 Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021–2028 (USD Million)
Figure 18 North America: Platelet Rich Plasma Therapy Market Snapshot
Figure 19 Europe: Platelet Rich Plasma Therapy Market Snapshot
Figure 20 Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players -2018–2021
Figure 22 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
Figure 23 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
Figure 24 Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
Figure 30 National Institute of Health, U.S. Funding for Regenerative Medicines, 2013–2022 (USD Million)
Figure 31 Johnson And Johnson: Financial Overview, 2020
Figure 32 Terumo Corporation.: Financial Overview, 2020
Figure 33 Stryker Corporation.: Financial Overview, 2020
Figure 34 Zimmer Biomet Holdings, Inc: Financial Overview, 2020
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Sep-2023
Published Date: Jul-2023
Published Date: May-2023
Published Date: Jul-2020
